Event: Gu Cancers 2019

Dr Toni Choueiri’s highlights from GU Cancers Symposium 2019

"All bladder, all the time" - Highlights from the 2019 Genitourinary Cancers Symposium

ASCO GU 2019: treatment and management of hormone-sensitive metastatic prostate cancer

Dr Caffo's highlights from the 2019 GU Cancers symposium

GU Debates 2019: Updates on genitourinary cancers (2/2)

Expert highlights: Genitourinary cancers at ESMO 2019 | Axel Merseburger

Medicine Matters oncology

Key prostate cancer news from GU 2019

Key bladder cancer updates from ASCO GU 2019

ASCO GU 2019 - Dr. Arjun V Balar, NYU Langone's Pearlmutter Cancer Center, USA

Oncology Information Group

Prostate cancer radiotherapy: an update from the 2019 Genitourinary cancers symposium

GU cancer: treating elderly patients

ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer (CRPC)

WeOncologists ESO Presents: BEST of ASCO GU 2019 by Manuel Maia

Best of ASCO 2019: Lung and Genitourinary Cancers - J. Weiss & T. Rose - 20190828

UNC Lineberger Cancer Network

ESMO 2019: Dr. Choueiri Discusses Novel Treatment Strategies in GU Cancers

ASCO GU 2019 - Dr. Andrew J. Armstrong, Duke University, NC, USA

Oncology Information Group

Cancer Patient Perspectives Panel at 2019 CRI Immunotherapy Patient Summit in Boston

Cancer Research Institute

Screening, Active Surveillance and Prostate Cancer Biomarkers

Weill Cornell Genitourinary (GU) Cancer Program

Managing patients with GU cancers in the time of COVID-19 | Cora Sternberg and Axel Merseburger

Medicine Matters oncology

Petros Grivas, MD | Key Takeaways on Genitourinary Cancer at 2019 ASCO Direct Highlights Denver

Total Health | Oncology